ALVOTECH SA (ALVO) Stock Fundamental Analysis

NASDAQ:ALVO • LU2458332611

4.64 USD
-0.07 (-1.49%)
At close: Feb 13, 2026
4.64 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALVO. ALVO was compared to 522 industry peers in the Biotechnology industry. ALVO has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALVO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ALVO had positive earnings in the past year.
  • In the past year ALVO has reported a negative cash flow from operations.
  • In the past 5 years ALVO always reported negative net income.
  • ALVO had a negative operating cash flow in each of the past 5 years.
ALVO Yearly Net Income VS EBIT VS OCF VS FCFALVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

  • ALVO's Return On Assets of 4.93% is amongst the best of the industry. ALVO outperforms 91.01% of its industry peers.
  • With an excellent Return On Invested Capital value of 3.10%, ALVO belongs to the best of the industry, outperforming 90.25% of the companies in the same industry.
Industry RankSector Rank
ROA 4.93%
ROE N/A
ROIC 3.1%
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVO Yearly ROA, ROE, ROICALVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • With an excellent Profit Margin value of 12.12%, ALVO belongs to the best of the industry, outperforming 91.78% of the companies in the same industry.
  • ALVO has a better Operating Margin (7.57%) than 90.25% of its industry peers.
  • ALVO has a better Gross Margin (55.59%) than 77.44% of its industry peers.
Industry RankSector Rank
OM 7.57%
PM (TTM) 12.12%
GM 55.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALVO Yearly Profit, Operating, Gross MarginsALVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALVO is destroying value.
  • Compared to 1 year ago, ALVO has more shares outstanding
  • ALVO has a better debt/assets ratio than last year.
ALVO Yearly Shares OutstandingALVO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M
ALVO Yearly Total Debt VS Total AssetsALVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ALVO has an Altman-Z score of -1.11. This is a bad value and indicates that ALVO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.11, ALVO perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.11
ROIC/WACC0.48
WACC6.53%
ALVO Yearly LT Debt VS Equity VS FCFALVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

  • A Current Ratio of 1.42 indicates that ALVO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.42, ALVO is doing worse than 81.45% of the companies in the same industry.
  • A Quick Ratio of 0.74 indicates that ALVO may have some problems paying its short term obligations.
  • The Quick ratio of ALVO (0.74) is worse than 87.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.74
ALVO Yearly Current Assets VS Current LiabilitesALVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • ALVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.99%, which is quite impressive.
  • Looking at the last year, ALVO shows a very strong growth in Revenue. The Revenue has grown by 426.84%.
  • ALVO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.86% yearly.
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%

3.2 Future

  • Based on estimates for the next years, ALVO will show a very strong growth in Earnings Per Share. The EPS will grow by 41.54% on average per year.
  • The Revenue is expected to grow by 33.06% on average over the next years. This is a very strong growth
EPS Next Y116.02%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue Next Year28.26%
Revenue Next 2Y36.14%
Revenue Next 3Y33.06%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALVO Yearly Revenue VS EstimatesALVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 500M 1B 1.5B
ALVO Yearly EPS VS EstimatesALVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.20, ALVO is valued on the expensive side.
  • Based on the Price/Earnings ratio, ALVO is valued cheaply inside the industry as 94.26% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.68. ALVO is around the same levels.
  • A Price/Forward Earnings ratio of 11.16 indicates a reasonable valuation of ALVO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 97.71% of the companies listed in the same industry.
  • ALVO is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.2
Fwd PE 11.16
ALVO Price Earnings VS Forward Price EarningsALVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 91.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.99
ALVO Per share dataALVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALVO's earnings are expected to grow with 41.54% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y57.41%
EPS Next 3Y41.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALVO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVOTECH SA

NASDAQ:ALVO (2/13/2026, 8:00:00 PM)

After market: 4.64 0 (0%)

4.64

-0.07 (-1.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)05-06
Inst Owners5.46%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)491.98M
Net Income(TTM)69.50M
Analysts78.33
Price Target8.93 (92.46%)
Short Float %1.94%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)206.21%
Min EPS beat(2)-145.1%
Max EPS beat(2)557.52%
EPS beat(4)3
Avg EPS beat(4)215.83%
Min EPS beat(4)-145.1%
Max EPS beat(4)557.52%
EPS beat(8)5
Avg EPS beat(8)737.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)18.13%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)41.02%
Revenue beat(4)3
Avg Revenue beat(4)25.91%
Min Revenue beat(4)-4.76%
Max Revenue beat(4)41.02%
Revenue beat(8)4
Avg Revenue beat(8)9.39%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-350%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.44%
Valuation
Industry RankSector Rank
PE 23.2
Fwd PE 11.16
P/S 2.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 33.99
EPS(TTM)0.2
EY4.31%
EPS(NY)0.42
Fwd EY8.96%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.84
BVpS-0.57
TBVpS-0.81
PEG (NY)0.2
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.93%
ROE N/A
ROCE 3.93%
ROIC 3.1%
ROICexc 3.23%
ROICexgc 3.47%
OM 7.57%
PM (TTM) 12.12%
GM 55.59%
FCFM N/A
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 15.52
Cap/Depr 313.02%
Cap/Sales 19.43%
Interest Coverage 1.69
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.74
Altman-Z -1.11
F-Score4
WACC6.53%
ROIC/WACC0.48
Cap/Depr(3y)204.72%
Cap/Depr(5y)182.09%
Cap/Sales(3y)39.66%
Cap/Sales(5y)47.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y116.02%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
Revenue Next Year28.26%
Revenue Next 2Y36.14%
Revenue Next 3Y33.06%
Revenue Next 5YN/A
EBIT growth 1Y306.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.05%
EBIT Next 3Y67.64%
EBIT Next 5YN/A
FCF growth 1Y61.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5YN/A

ALVOTECH SA / ALVO FAQ

What is the ChartMill fundamental rating of ALVOTECH SA (ALVO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALVO.


What is the valuation status of ALVOTECH SA (ALVO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALVOTECH SA (ALVO). This can be considered as Fairly Valued.


Can you provide the profitability details for ALVOTECH SA?

ALVOTECH SA (ALVO) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALVO stock?

The Earnings per Share (EPS) of ALVOTECH SA (ALVO) is expected to grow by 116.02% in the next year.